Conference
Impact of number of lines of prior chemotherapy in patients (pts) with advanced urothelial carcinoma (UC) receiving salvage therapy.
Abstract
353
Background: The prognostic impact of number of lines of prior chemotherapy and prior perioperative chemotherapy on survival results in salvage trials for advanced UC is unknown. Methods: We pooled 10 prospective phase II trials of salvage therapy for advanced UC with data on the number of prior lines of therapy in addition to known prognostic factors: TFPC (time from prior chemotherapy), Hb (hemoglobin), PS (performance …
Authors
Sonpavde G; Bellmunt J; Rosenberg JE; Bajorin DF; Regazzi AM; Choueiri TK; Qu AQ; Niegisch G; Albers P; Necchi A
Volume
32
Pagination
pp. 353-353
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 1, 2014
DOI
10.1200/jco.2014.32.4_suppl.353
Conference proceedings
Journal of Clinical Oncology
Issue
4_suppl
ISSN
0732-183X